Linde PLC (LIN) Stock News

Rosen Law Firm is reminding Black Rock Coffee Bar, Inc. investors of an August 17, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that defendants made materially false statements and failed to disclose that new store openings were cannibalizing existing revenue through 'sales transfer,' materially impacting financial results.

Rosen Law Firm has filed a class action lawsuit against Wise Group plc (NASDAQ: WSE) on behalf of investors who purchased securities between May 11, 2026 and July 23, 2026. The lawsuit alleges that defendants made false and misleading statements by materially understating regulatory risks related to anti-money laundering and terrorism financing prevention efforts ahead of the company's NASDAQ debut. Investors who purchased during the class period may be entitled to compensation.

Rosen Law Firm is notifying Microsoft investors of an August 11, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Microsoft made false statements regarding its Copilot AI products, which allegedly experienced significant technical and market share problems, and that the company failed to disclose the need for billions in additional capital expenditures and GPU/CPU capacity diversion from Azure services to improve Copilot's competitive positioning.

Rosen Law Firm is encouraging investors who suffered losses exceeding $100,000 in Peabody Energy Corporation (BTU) to join a securities class action lawsuit. The lawsuit alleges that Peabody Energy provided misleading statements about its Centurion mine operations, with actual Q1 2026 output reaching only 250,000 tons versus previously estimated 700,000 tons. The lead plaintiff deadline is August 24, 2026. Similar class actions are also being pursued against ADMA Biologics and Microvast Holdings.

Rosen Law Firm reminds investors of the August 10, 2026 deadline to join a securities class action lawsuit against ADMA Biologics. The lawsuit alleges the company made materially false statements regarding undisclosed related party transactions, channel stuffing, and inadequate internal controls that artificially inflated revenue during the class period from August 9, 2024 to March 25, 2026.

Rosen Law Firm announces a securities class action lawsuit against Futu Holdings Limited for allegedly making materially false statements regarding regulatory compliance with China's Securities Regulatory Commission. The lawsuit claims Futu conducted securities, public fund sales, and futures business in mainland China without proper licenses or approvals, leading to overstated financial results. The lead plaintiff deadline is August 25, 2026.

Rosen Law Firm has filed securities class action lawsuits against Blaize Holdings, Inc., Datavault AI Inc., and Planet Fitness, Inc. on behalf of investors who purchased securities during specified periods. The lawsuits allege false statements, misleading disclosures, and improper revenue recognition. Investors have until October 5, 2026 to move the court if they wish to serve as lead plaintiff.

A securities class action lawsuit has been filed against Erasca, Inc. and its executives for allegedly making false and misleading statements about its lead oncology drug candidate ERAS-0015. The company is accused of improperly comparing its drug to a competitor's candidate and failing to disclose patent and trade secret disputes. Investors who purchased Erasca stock between January 14, 2025 and April 26, 2026 must act by August 10, 2026 to serve as lead plaintiff.

ADMA Biologics is facing a securities fraud class action lawsuit alleging misrepresentations regarding financial condition, revenue recognition, and undisclosed related-party transactions. A short-seller report in March 2026 revealed channel stuffing and improper accounting practices, causing the stock to plunge 31.6% over two trading days. The lawsuit covers the period from August 9, 2024 to March 25, 2026, with a lead plaintiff deadline of August 10, 2026.

A class action lawsuit has been filed against Erasca, Inc. alleging that the company made false and misleading statements regarding its ERAS-0015 drug candidate. The lawsuit claims the preclinical data was based on improper comparisons and lacked reasonable basis. Following a patent infringement allegation from Revolution Medicines disclosed on April 28, 2026, Erasca's stock price declined approximately 48% from $19.15 to $9.90 per share. Investors have until August 10, 2026 to apply as lead plaintiff.

Black Rock Coffee Bar, Inc. (NASDAQ: BRCB) is facing a securities class action lawsuit alleging the company made false and misleading statements about its expansion strategy during its September 2025 IPO. The complaint claims management concealed significant 'sales transfer' (cannibalization) issues caused by aggressive store density expansion, which eroded same-store sales growth. The stock has declined over 61% from its IPO price to $7.72 as of June 2026. The lead plaintiff deadline is August 17, 2026.

Hagens Berman is investigating securities fraud claims against Erasca, Inc. for allegedly misleading investors about its lead oncology drug ERAS-0015's competitive advantages, safety profile, and intellectual property protections. The company faces patent infringement allegations from Revolution Medicines and reported a patient death in clinical trials, triggering a $2.8 billion market capitalization loss. Investors with substantial losses can serve as lead plaintiffs with an August 10, 2026 deadline.

Rosen Law Firm is reminding investors in Zillow Group, Embecta Corp, and GoDaddy Inc. of upcoming lead plaintiff deadlines in securities class actions. The Zillow lawsuit alleges the company made false statements regarding its Redfin agreement and antitrust risks. Investors with losses exceeding $100K are encouraged to contact the firm before the respective deadlines.

A securities class action lawsuit has been filed against Nano-X Imaging Ltd. (NNOX) for allegedly making false and misleading statements about operational efficiency and product demand. The lawsuit claims the company overstated efficiency gains while concealing poor alignment between production and demand, leading to increased operating expenses, cash burn, and the need for disruptive restructuring measures. Investors with losses exceeding $100,000 are encouraged to join the class action before the August 11, 2026 deadline.

A class action lawsuit has been filed against BitGo Holdings, Inc. (NYSE: BTGO) alleging that the company's IPO offering documents were negligently prepared and contained false or misleading statements. The lawsuit claims BitGo understated risks related to declining digital asset prices and lacked a reasonable basis for statements about its financial performance and business prospects. Investors who purchased BitGo securities between January 22, 2025 and May 13, 2026 have until August 7, 2026 to apply to be appointed as lead plaintiff.

A securities class action lawsuit has been filed against Black Rock Coffee Bar, Inc. for allegedly making materially false statements in its IPO registration statement and throughout the Class Period (September 12, 2025 - May 12, 2026). The lawsuit claims defendants failed to disclose that new store openings were cannibalizing existing revenue through 'sales transfer,' materially impacting financial results. Investors with losses exceeding $100K are encouraged to join the class action before the August 17, 2026 lead plaintiff deadline.

Rosen Law Firm announces a securities class action lawsuit against Roblox Corporation, alleging the company made materially false and misleading statements about its organic growth potential. The lawsuit claims Roblox concealed that age verification rollout would cause significant growth slowdown, reduced on-platform communication, and declining app store ratings. The lead plaintiff deadline is August 7, 2026.

ADMA Biologics is facing a securities class action lawsuit alleging the company made false statements regarding undisclosed related party transactions, channel stuffing schemes, and inadequate internal controls. A Culper Research report claimed ADMA's reported 20% growth in 2025 was artificially inflated, with actual revenue declining 3% when adjusted for extended payment terms. The stock declined over 16% following the report, and an additional 13% after a Cantor Fitzgerald downgrade. Investors with substantial losses can seek lead plaintiff status by Monday, August 10, 2026.

Class action lawsuits have been filed against four publicly-traded companies for alleged securities fraud. Futu Holdings faces allegations of non-compliance with Chinese regulatory requirements, First Solar allegedly overstated its ability to manage tariff impacts, Black Rock Coffee Bar allegedly misrepresented its expansion strategy and cannibalization effects, and ADMA Biologics allegedly engaged in undisclosed related party transactions and channel stuffing. Investors have until mid-to-late August 2026 to file lead plaintiff motions.

A securities fraud class action lawsuit has been filed against ADMA Biologics, Inc. alleging misrepresentations concerning financial condition, revenue recognition, and undisclosed related-party transactions. The lawsuit covers the period from August 9, 2024 to March 25, 2026. Following a short-seller report by Culper Research on March 24, 2026 revealing channel stuffing and undisclosed distributor Genesis BioPharma, ADMA's stock plummeted 31.6% over two trading days, with further declines following a rating downgrade.

Hagens Berman is investigating Embecta Corp. (NASDAQ: EMBC) for allegedly misleading investors about the stability of its insulin pen needle business. The company claimed its pen needle portfolio was 'stable' and 'resilient' while experiencing significant competitive share loss and market volume softness. On May 5, 2026, Embecta revealed massive revenue declines, slashed full-year 2026 adjusted EPS guidance by 43%, and cut its quarterly dividend by 93%, causing the stock to plummet 57.8% in a single trading day. Investors with substantial losses during the class period (Nov. 25, 2025 – May 4, 2026) are encouraged to participate in the lawsuit with a lead plaintiff deadline of August 17, 2026.

Hagens Berman has expanded a securities class action lawsuit against Roblox Corporation (RBLX), covering investors who purchased stock between October 31, 2024 and April 30, 2026. The lawsuit alleges that Roblox misled investors about its safety commitments and the impact of its age verification rollout, which began in November 2025. The announcement of enhanced age verification caused a 16% stock decline, and subsequent disclosures revealed significant DAU growth deceleration, reduced app store ratings, and slashed revenue guidance, with only 51% of global DAUs completing age verification.

A securities class action lawsuit has been filed against Futu Holdings Limited for allegedly making materially false statements regarding compliance with China Securities Regulatory Commission requirements. The lawsuit claims Futu conducted securities, public fund sales, and futures business in mainland China without proper licenses or approvals, leading to overstated financial results. Investors with losses exceeding $100K are encouraged to join the class action before the August 25, 2026 lead plaintiff deadline.

A federal securities class action has been filed against Roblox Corporation alleging that executives made false and misleading statements about the company's organic growth potential. The lawsuit claims Roblox concealed that its age verification rollout would significantly slow growth rates and reduce engagement. On April 30, 2026, when Roblox revealed the true impact, its stock plummeted 18.33% in a single day from $55.26 to $45.13 per share. Investors who purchased RBLX securities between October 31, 2024 and April 30, 2026 may be eligible to participate, with a deadline of August 7, 2026 to seek lead plaintiff appointment.

Class action lawsuits have been filed against four publicly-traded companies alleging securities fraud. Erasca faces allegations regarding misleading preclinical data comparisons; Via Transportation failed to disclose declining ARR and regulatory issues; Embecta misrepresented guidance and segment weakness; and Zillow mischaracterized its Redfin agreement and downplayed antitrust risks. Investors have until mid-August 2026 to file lead plaintiff motions.

A securities class action lawsuit has been filed against BitGo Holdings, Inc. (NYSE: BTGO) alleging that offering documents and statements made during its January 2026 IPO and through May 2026 contained material misstatements and omissions. Specifically, the lawsuit claims BitGo understated risks from declining digital asset prices and made false statements about its financial performance and business prospects. Investors who purchased BTGO securities have until August 7, 2026 to become lead plaintiffs.

Rosen Law Firm is reminding Zillow Group investors of the August 10, 2026 deadline to serve as lead plaintiff in a securities class action lawsuit. The lawsuit alleges that Zillow made materially false and misleading statements regarding its agreement with Redfin Corporation, mischaracterizing an acquisition as a partnership, and downplaying regulatory and antitrust risks. Investors who purchased Zillow common stock between February 11, 2025 and May 7, 2026 may be eligible for compensation.

Law Offices of Howard G. Smith announced class action lawsuits against three publicly-traded companies for securities fraud. Insulet Corporation faces allegations of defective manufacturing controls, Microvast Holdings is accused of overstating margin targets and expansion timelines, and Hub Group is charged with material misstatements in financial reporting. Investors have until late August and September 2026 to file lead plaintiff motions.

Robbins Geller Rudman & Dowd LLP is seeking a lead plaintiff for a securities class action lawsuit against Erasca, Inc. The lawsuit alleges that Erasca made false and misleading statements regarding its ERAS-0015 drug candidate, including improper comparisons to competitor Revolution Medicines' technology and undisclosed patent infringement risks. Following disclosure of a patent infringement letter and adverse clinical trial data on April 27, 2026, Erasca's stock price fell approximately 59% combined. The deadline to apply as lead plaintiff is August 10, 2026.

Rosen Law Firm announces securities class action lawsuits against multiple companies. Verra Mobility is accused of making false statements about its relationship with Avis Budget Group and concealing material adverse facts. Hub Group and Alarum Technologies are also subjects of investigations for potential securities violations. Investors are urged to secure counsel before upcoming deadlines.